glp 1 and spironolactone Established Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond Structure-Based Discovery of Orthosteric Non-Peptide

Medically reviewed by Dr

A Senate-passed proposal to restore access to GLP-1 medications for weight loss on the Medicaid program got a big thumbs-down from a critical House committee Wednesday

Possible Side Effects Tirzepatide may cause: Nausea Constipation Diarrhea Decreased appetite Temporary fatigue Gradual dose titration improves tolerability

Back Chaiborn, C (1 Aug 2011) 'Masters of metabolism: Matthias Tschp and Richard DiMarchi', The Journal of Clinical Investigation , 121/8, 2952

Mounjaro Zepbound and Mounjaro both contain tirzepatide, but they are FDA-approved for different uses

Lancet Diabetes Endocrinol (2017) 5(5):34154